Search

everythinglearnresearchcommunity

for

Search:↓

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The enzyme PA-PLA1α is important for proper hair follicle development.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

EGFR signaling is essential for ear cell regeneration in both birds and mammals.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

EGFR helps control how hair grows and forms without needing p53 protein.

Epiregulin can help hair grow and may be useful for treating hair loss.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Piperonylic acid may help hair growth and treat hair loss.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.